389, Jun
In summary, therapeutic management of secondary DM in acromegalic patients should be based on a combination of metformin and GLP1-RA, as a first therapeutic approach, in line with the latest scientific evidence, in order to take advantage of the cardioprotective effects of GLP1-RA
The FDA also restricted it from legal compounding in 2023, so any source youre using is operating outside the licensed pharmacy system
Both medications reduce appetite, but their mechanisms and safety profiles differ significantly, and combining them requires careful medical consideration
Lean proteins: Opt for sources like chicken, fish, and plant-based alternatives to support muscle health without excessive fat
Understanding the Myers' Cocktail The Myers' Cocktail is named after Dr